Delivery Order SPE2DB24D2010-SPE2DB25FAAGA
- Not listed
- This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,050.21. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $3,583.59 and is a Firm Fixed Price Delivery Order contract with an ultimate completion date of August 1, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
- This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a ceiling value of $3,111.61. The contract has a completion date of July 16, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $1,705.58. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order with a Firm Fixed Price of $1,267.14 and an Ultimate...
- This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,702.34 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, through the DLA's Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The IDC serves as a primary vehicle for providing a range of pharmaceutical products and medical supplies to support military...
- This federal contract award is for the delivery of BRIVIACT 50 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $6,141.68 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 10, 2024, with a completion date of June 11, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with...
- This federal contract award is for the pharmaceutical product BRIVIACT 100 MG TABLET 60S, with a ceiling value of $1,009.83. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen...
- This federal contract award is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a total ceiling value of $1,036.29 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The contract is not...
- This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,510.54, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FAAGADelivery Order
This federal contract award is for the delivery of BRIVIACT 10 MG/ML ORAL SOLN 300ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,995.34 and is a firm fixed price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/9/25 |